Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Study Demonstrates Feasibility of Tracking Mutations in Multiple Genes with Circulating Tumor DNA

Study Demonstrates Feasibility of Tracking Mutations in Multiple Genes with Circulating Tumor DNA

May 30, 2012
|
staff reporter

NEW YORK (GenomeWeb News) – In Science Translational Medicine, researchers from the UK and the US have demonstrated the feasibility of doing blood-based 'liquid biopsies' using a targeted deep sequencing strategy that can uncover mutations in several genes using tumor DNA that is circulating in the bloodstream.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Genomics to Trace, Prevent

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Sense of Scope in San Diego

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Boost to Wolf Diversity

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

Science Papers Present Algorithm to Diagnose Slowly Progressing Diseases, Korean Genome Project

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

What's Popular?

In Clinical Sequencing

  1. Patients Having Ovaries Removed Without Clear Genetic, Medical Rationale, Study Suggests

    Premium

  2. BTIG Initiates Coverage of Fulgent Genetics

  3. Illumina, Genomic Medicine Sweden to Evaluate Sequencing-Based Leukemia Diagnostics

  4. Fry Laboratories Plans COVID-19 NGS Diagnostic Kit Offering

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.